Logos Global Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001792126

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2025 · 67 positions · Total reported value $1.39B · Top-10 concentration 43.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.7% · 25 new · 19 cut · 20 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +22.9% · vs SPY +8.1% · Prev Value $1.89B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2025 13F filing, Logos Global Management LP disclosed 67 equity positions with a combined reported value of $1.39B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 43.6% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were PRAX ($110.53M), OLMA ($80.22M), RVMD ($79.65M). By sector, the heaviest allocations are Health Care 86.4%, Other 13.6%. Versus the prior quarter, allocation shifted toward Health Care (+4.6pp) and away from Other (-4.6pp).

Versus the prior quarter, Logos Global Management LP opened 25 new positions, trimmed 19 and fully exited 20, a turnover rate of 72.7% of positions. The portfolio's overlap with the prior quarter was 54% of names.

The largest new positions opened in Q4 2025 were TERN ($30.30M), RCUS ($25.02M), MLTX ($23.07M).

Of the 20 positions fully exited versus the prior quarter, the largest were AKRO ($56.98M), ARVN ($47.50M), PTGX ($19.93M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • TERN TERNS PHARMACEUTICALS INC · $30.30M
  • RCUS ARCUS BIOSCIENCES INC · $25.02M
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · $23.07M
  • ACAD ACADIA PHARMACEUTICALS INC · $22.70M
  • CYTK CYTOKINETICS INC · $19.06M
  • MIRM MIRUM PHARMACEUTICALS INC · $17.77M
  • NAMS NEWAMSTERDAM PHARMA COMPANY · $15.79M
  • KNSA KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A · $14.44M

Fully Exited (vs previous quarter)

  • AKRO AKERO THERAPEUTICS INC · prev qtr: $56.98M
  • ARVN ARVINAS INC · prev qtr: $47.50M
  • PTGX PROTAGONIST THERAPEUTICS INC · prev qtr: $19.93M
  • KROS KEROS THERAPEUTICS INC · prev qtr: $13.45M
  • LRMR Larimar Therapeutics Inc · prev qtr: $8.07M
  • COGT COGENT BIOSCIENCES INC · prev qtr: $7.18M · history
  • IMRX IMMUNEERING CORP · prev qtr: $6.65M
  • SRRK SCHOLAR ROCK HLDG CORP · prev qtr: $6.52M · history

Insider Transactions (Form 4)

Latest Logos Global Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Logos Global Management LP is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 68 US equity positions with a combined value of $2.32B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-117248 (status: Approved), registered 2019-08-26
  • Regulatory AUM (Form ADV): $2.25B as of 2026-04-22
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds, of which 1 hedge funds

Portfolio Structure

  • 68 positions · $2.32B reported value (Q2 2026)
  • Top 10 holdings = 48.3% of reported value
  • Largest position: ERAS (ERASCA INC COM) at 9.6%
  • Average position size: $34.16M

Sector Tilt

  • Health Care 99.1%
  • Financials 0.1%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 25 new, 18 added, 19 reduced, 20 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 86.4%
Other 13.6%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 375.00K $110.53M 7.96%
7.96%
Add
2 3.21M $80.22M 5.78%
5.78%
Hold
3 1.00M $79.65M 5.74%
5.74%
Hold
4 310.00K $68.48M 4.93%
4.93%
Reduce
5 400.00K $53.94M 3.89%
3.89%
Reduce
6 13.00M $48.36M 3.48%
3.48%
Reduce
7 3.50M $42.49M 3.06%
3.06%
Add
8 600.00K $41.73M 3.01%
3.01%
Reduce
9 510.00K $40.50M 2.92%
2.92%
Add
10 950.00K $39.36M 2.84%
2.84%
Reduce
11 4.20M $37.21M 2.68%
2.68%
Add
12 500.00K $36.06M 2.60%
2.60%
Reduce
13 200.00K $35.20M 2.54%
2.54%
Add
14 1.38M $34.95M 2.52%
2.52%
Add
15 200.00K $34.00M 2.45%
2.45%
Hold
16 750.00K $30.30M 2.18%
2.18%
New
17 650.00K $29.99M 2.16%
2.16%
Add
18 850.00K $29.50M 2.13%
2.13%
Hold
19 1.20M $26.71M 1.93%
1.93%
Add
20 1.00M $25.12M 1.81%
1.81%
Hold
21 1.05M $25.02M 1.80%
1.80%
New
22 1.25M $24.45M 1.76%
1.76%
Reduce
23 2.50M $23.45M 1.69%
1.69%
Reduce
24 1.75M $23.07M 1.66%
1.66%
New
25 850.00K $22.70M 1.64%
1.64%
New
26 190.00K $20.34M 1.47%
1.47%
Reduce
27 1.55M $19.41M 1.40%
1.40%
Reduce
28 300.00K $19.06M 1.37%
1.37%
New
29 225.00K $17.77M 1.28%
1.28%
New
30 675.00K $16.15M 1.16%
1.16%
Add
31 450.00K $15.79M 1.14%
1.14%
New
32 450.00K $15.56M 1.12%
1.12%
Hold
33 350.00K $14.44M 1.04%
1.04%
New
34 300.00K $13.89M 1.00%
1.00%
New
35 1.00M $13.80M 0.99%
0.99%
Add
36 3.31M $13.31M 0.96%
0.96%
New
37 1.70M $13.12M 0.95%
0.95%
Reduce
38 315.00K $12.98M 0.94%
0.94%
Add
39 950.00K $11.48M 0.83%
0.83%
Reduce
40 130.00K $10.12M 0.73%
0.73%
Reduce
41 350.00K $9.51M 0.69%
0.69%
New
42 500.00K $9.48M 0.68%
0.68%
New
43 850.00K $8.93M 0.64%
0.64%
New
44 200.00K $8.30M 0.60%
0.60%
New
45 115.00K $7.50M 0.54%
0.54%
Reduce
46 600.00K $7.12M 0.51%
0.51%
Hold
47 1.15M $6.18M 0.45%
0.45%
Reduce
48 395.00K $6.09M 0.44%
0.44%
Reduce
49 210.00K $5.52M 0.40%
0.40%
New
50 340.00K $5.24M 0.38%
0.38%
Hold

FAQ

What did Logos Global Management LP buy in 2025-Q4?

In its 2025-Q4 13F filing, Logos Global Management LP reported 67 equity positions worth $1.39B in aggregate; its largest disclosed positions were PRAX ($110.53M), OLMA ($80.22M), RVMD ($79.65M).

How large is Logos Global Management LP's portfolio?

Logos Global Management LP reported $1.39B of long equity holdings across 67 positions as of 2025-Q4. Top-10 holdings account for 43.6% of reported value.

What is Logos Global Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/logos-global-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →